ProSciento’s Clinical Development services are tailored to the specific needs of our clients and typically begin with a well-defined target product profile and clinical development plan. Clients work with our team of seasoned professionals, comprised of PhD and MD level scientists with extensive track records in metabolic drug and device development, at every step of the process from early development planning through regulatory submissions and licensing opportunities.
Clients often choose to partner with ProSciento because of the depth and scalable nature of our clinical development services, combined with deep scientific and therapeutic expertise in metabolic diseases—providing distinct advantages for this early stage of compound strategy and development.
